Our Group and Brands
At Bioxyne we believe in brand power. From our pharmaceuticals to our consumer health products, our label stands for trust and quality.
Scroll Down
Our Company
Bioxyne Ltd & Breathe Life Sciences
Bioxyne Ltd (ASX: BXN | FSE: PR8) is an Australian life sciences company engaged in the research, development, manufacturing, and global distribution of consumer health products, therapeutic goods, and controlled medicines. For over 15 years, our unique formulations, healthcare solutions, and patient-focused approach have helped improve the lives of people around the world.
The Bioxyne Group operates across Australasia, Europe, and the Americas.
Breathe Life Sciences (BLS) is a wholly-owned subsidiary of Bioxyne Ltd. BLS is a licensed pharmaceutical manufacturer, sponsor, importer, and exporter of Schedule 3, Schedule 4, and Schedule 8 controlled substances in Australia. Our operations span regulated medical supply chains, advanced formulation development, and international wholesale distribution networks.
BLS is at the forefront of alternative and investigational medicines — developing safer, more effective, and clinically guided treatments for unmet patient needs. Our work is grounded in a rigorous scientific foundation, strong regulatory compliance, and a commitment to delivering high-quality healthcare products that improve and prolong life.
BXN Brands
Our Brands
From our pharmaceuticals to our consumer health products, our label stands for quality and trust. Our vision as a group has been to focus on data-driven product and process development, building world class pharmaceutical service levels from procurement to manufacture and distribution. We operate as an industry partner, helping our clients build and grow compliantly.
As a life sciences company, our work, products and services are dedicated to improving quality of life as well as ease of access to therapeutic goods for unmet needs. We operate in nascent markets and aspire to change the way the world prevents and treats disease with unregistered alternative medicines, consumer health products, and technology.
